Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by carduon Feb 09, 2011 7:51pm

284 Views

Post# 18105964

RE: RE: RE: RE: ONCY Short up Need Your Help To Un

JL, as you are a kind of pedantic person who feels obliged to point out other's shortcomings, I feel obliged to point out that you have erred in two spelling mistakes in your last post.

As a graduate in the field of Psychology I wished you had been around when Sigmund Freud was practising. He could have filled a text book based on your observations.

To support Sharkfood's comments on Mr. Thomson I would suggest that Brad's eptitaph should read, " Absolutely".

Bullboard Posts

Thunder Gold makes generational discovery